Vincenzo Di Nunno

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 40

Top Topics

Prostate Cancer

Top Venues

Expert opinion on drug discovery

Journal of neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Stefania Bartolini, Enrico Franceschi
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults. CNS oncology 13 (1) (2024)
Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Stefania Bartolini, Enrico Franceschi
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults. CNS oncology 13 (1) (2024)
Vincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, Giuseppe Minniti, Angela Mastronuzzi, Valentina Di Ruscio, Martina Corrà, Marta Padovan, Marta Maccari, Mario Caccese, Giorgia Simonetti, Arianna Berlendis, Mariangela Farinotti, Bianca Pollo, Manila Antonelli, Antonio Di Muzio, Angelo Dipasquale, Sofia Asioli, Dario De Biase, Alicia Tosoni, Antonio Silvani, Enrico Franceschi
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study. Journal of neuro-oncology 167 (1) (2024)
Vincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, Giuseppe Minniti, Angela Mastronuzzi, Valentina Di Ruscio, Martina Corrà, Marta Padovan, Marta Maccari, Mario Caccese, Giorgia Simonetti, Arianna Berlendis, Mariangela Farinotti, Bianca Pollo, Manila Antonelli, Antonio Di Muzio, Angelo Dipasquale, Sofia Asioli, Dario De Biase, Alicia Tosoni, Antonio Silvani, Enrico Franceschi
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study. Journal of neuro-oncology 167 (1) (2024)
Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Stefania Bartolini, Enrico Franceschi
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults. CNS oncology 13 (1) (2024)
Vincenzo Di Nunno, Lidia Gatto, Marta Aprile, Stefania Bartolini, Alicia Tosoni, Enrico Franceschi
Economic income and survival in patients affected by glioblastoma: A systematic review and meta-analysis. Neuro-oncology practice 11 (5) (2024)
Vincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, Giuseppe Minniti, Angela Mastronuzzi, Valentina Di Ruscio, Martina Corrà, Marta Padovan, Marta Maccari, Mario Caccese, Giorgia Simonetti, Arianna Berlendis, Mariangela Farinotti, Bianca Pollo, Manila Antonelli, Antonio Di Muzio, Angelo Dipasquale, Sofia Asioli, Dario De Biase, Alicia Tosoni, Antonio Silvani, Enrico Franceschi
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study. Journal of neuro-oncology (2024)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022. Expert opinion on drug discovery 18 (3) (2023)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes
Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022. Expert opinion on drug discovery (2023)
Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Enrico Franceschi
Letter concerning "Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival": Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma. Neuro-oncology (2023)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022. Expert opinion on drug discovery 18 (3) (2023)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022. Expert opinion on drug discovery 18 (3) (2023)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022. Expert opinion on drug discovery (2023)
Vincenzo Di Nunno, Caterina Giannini, Sofia Asioli, Alfredo Conti, Julia Furtner, Damiano Balestrini, Alicia Tosoni
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3. Cancers 14 (19) (2022)
Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Ilaria Maggio, Raffaele Lodi, Alba Ariela Brandes
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem. Expert review of anticancer therapy 21 (12) (2022)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments. Expert review of clinical pharmacology 16 (1) (2022)
Vincenzo Di Nunno, Mario Fordellone, Giuseppe Minniti, Sofia Asioli, Alfredo Conti, Diego Mazzatenta, Damiano Balestrini, Paolo Chiodini, Raffaele Agati, Caterina Tonon, Alicia Tosoni, Lidia Gatto, Stefania Bartolini, Raffaele Lodi, Enrico Franceschi
Machine learning in neuro-oncology: toward novel development fields. Journal of neuro-oncology 159 (2) (2022)
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date? Drugs 82 (5) (2022)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments. Expert review of clinical pharmacology 16 (1) (2022)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes
Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream? Immunotherapy 14 (10) (2022)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments. Expert review of clinical pharmacology (2022)
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Antonella Mura, Santino Minichillo, Monica Di Battista, Lidia Gatto, Ilaria Maggio, Raffaele Lodi, Stefania Bartolini, Alba Ariela Brandes
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer? Clinical drug investigation 41 (9) (2021)
Enrico Franceschi, Dario de Biase, Vincenzo Di Nunno, Annalisa Pession, Alicia Tosoni, Lidia Gatto, Giovanni Tallini, Michela Visani, Raffaele Lodi, Stefania Bartolini, Alba Ariela Brandes
IDH1 Non-Canonical Mutations and Survival in Patients with Glioma. Diagnostics (Basel, Switzerland) 11 (2) (2021)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alba Ariela Brandes
BET inhibitors: the promise of a new generation of immunotherapy in glioblastoma. Immunotherapy (2021)
Ilaria Maggio, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon, Alba Ariela Brandes
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light. Expert review of anticancer therapy 21 (11) (2021)
Ilaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Daniele Angelini, Stefania Bartolini, Raffaele Lodi, Alba Ariela Brandes
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets. Diagnostics (Basel, Switzerland) 11 (10) (2021)
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alba Ariela Brandes
Chimeric antigen receptor macrophage for glioblastoma immunotherapy: the way forward. Immunotherapy 13 (11) (2021)
Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, Raffaele Lodi, Alba Ariela Brandes
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS oncology 10 (2) (2021)
Vincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, Ilaria Maggio, Lidia Gatto, Alicia Tosoni, Raffaele Lodi, Enrico Franceschi, Alba Ariela Brandes
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases. Immunotherapy 13 (5) (2021)
Alba Ariela Brandes, Andrea Ardizzoni, Fabrizio Artioli, Federico Cappuzzo, Luigi Cavanna, Giovanni Luca Frassineti, Antonio Frassoldati, Francesco Leonardi, Giuseppe Longo, Antonio Maestri, Davide Tassinari, Enrico Franceschi, Vincenzo Di Nunno, Carmine Pinto
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy. Future oncology (London, England) 16 (20) (2020)
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Monica Di Battista, Lidia Gatto, Cinzia Lamperini, Santino Minichillo, Antonella Mura, Stefania Bartolini, Alba Ariela Brandes
Treatment of recurrent glioblastoma: state-of-the-art and future perspectives. Expert review of anticancer therapy 20 (9) (2020)
Francesco Massari, Veronica Mollica, Vincenzo Di Nunno, Lidia Gatto, Matteo Santoni, Marina Scarpelli, Alessia Cimadamore, Antonio Lopez-Beltran, Liang Cheng, Nicola Battelli, Rodolfo Montironi, Giovanni Brandi
The Human Microbiota and Prostate Cancer: Friend or Foe? Cancers 11 (4) (2019)
Veronica Mollica, Vincenzo Di Nunno, Lidia Gatto, Matteo Santoni, Marina Scarpelli, Alessia Cimadamore, Antonio Lopez-Beltran, Liang Cheng, Nicola Battelli, Rodolfo Montironi, Francesco Massari
Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor. Cancers 11 (6) (2019)
Veronica Mollica, Vincenzo Di Nunno, Lidia Gatto, Matteo Santoni, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi, Salvatore Pisconti, Nicola Battelli, Francesco Massari
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution. Clinical drug investigation 39 (6) (2019)
Veronica Mollica, Vincenzo Di Nunno, Alessia Cimadamore, Antonio Lopez-Beltran, Liang Cheng, Matteo Santoni, Marina Scarpelli, Rodolfo Montironi, Francesco Massari
Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer. Cells 8 (1) (2019)
Matteo Santoni, Alessia Cimadamore, Francesco Massari, Francesco Piva, Gaetano Aurilio, Angelo Martignetti, Marina Scarpelli, Vincenzo Di Nunno, Lidia Gatto, Nicola Battelli, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi
Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers. Cancers 11 (9) (2019)